ZymaDerm is plant-based, non-toxic, painless, and contains no drugs. Our medical director, an M.D. research scientist with a dozen publications in peer-reviewed medical journals and over 10 years of clinical practice developed ZymaDerm. Each of the agents contained in ZymaDerm has found use for treating skin conditions. However, our proprietary blend has dramatically improved the overall effectiveness and is patent pending.

We used ZymaDerm in our own practice under close supervision for over 2 years before making it available to the public. There have been no reports of long term side effects from the use of ZymaDerm. 2 years of follow up is commonly required by the FDA prior to release of a new regulated drug. About 1/3000 persons will develop a sensitization reaction to ZymaDerm that shows itself as irritation, itching, or redness spreading beyond the area of the molluscum or herpes bump itself. If you or your child experience any discomfort or irritation from ZymaDerm, discontinue use.

The components of ZymaDerm have a long history of safe use topically for skin problems.

ZymaDerm may safely be applied to the face, genitals, and all other areas of the skin. You may use on the lips but not in the oral cavity such as the inside of the cheeks (buccal mucosa) or on the tongue. Care should be taken to avoid getting ZymaDerm in the eyes as it will sting. If this should happen, flush with lots of warm tap water. Each bottle comes with a glass rod applicator or a small brush to facilitate application to the molluscum bump and minimize contact with normal skin. ZymaDerm is non-caustic and will not harm normal skin, but an occasional sensitization of the skin can occur resulting in some redness and irritation. For molluscum bumps near the eye, one customer kindly shared this idea with us: use the head of a pin (not the pointed end...ouch!) to apply enough ZymaDerm to moisten the bump but not so much that it runs off into the eye. Thank you for that useful suggestion!

ZymaDerm conforms to standards specified in the U.S.H. Pharmacopeia. The FDA recognizes the U.S.H. Pharmacopeia as an official authoritative compendium. If an agent is listed in the Pharmacopeia for treating certain conditions, a product containing that agent may be marketed for those conditions without specific FDA approval. The approval has already been granted for those agents listed as long as the concentrations used in the product are within the specified limits. This is equivalent to the FDA OTC Monograph system. ZymaDerm meets these criteria. Thus, it could be considered 'FDA Compliant', although there is no such FDA category as 'FDA Compliant'. For more information you may search FDA regulations in the Code of Federal Regulations (CFR). See www.fda.gov. Search Title 21 of the CFR.

.......................................................................................Buy Now

.............................................About CBR Inc. .....Safety.... Research..... FAQ......Testimonials

......................................................Contact Us......Home.......About ZymaDerm......Links

ZymaDerm is classified as homeopathic to indicate its conformity to standards set forth in the U.S. Homeopathic Pharmacopeia.